Geometry Dash APK Hill Climb Racing APK
87.2 F
New York
Monday, August 8, 2022

Vitality Biopharma Inc (OTCMKTS:VBIO) Cannabinoids Take on “Superbug”

Must read

Is Tilray Inc (NASDAQ:TLRY) Stock a Good Buy After The Recent Fall?

The cannabis sector may have had a hard time not too long ago but over the course of the past months, the...

Sysorex Inc (OTCMKTS:SYSX) Stock Still Riding Big News

Investors are always drawn to stocks that make a big jump out of nowhere. So it's no surprise that Sysorex Inc (OTCMKTS:SYSX)...

88 Energy Limited Ltd (EEENF) Update: Continues Climbing on Significant Volume

Investors who might be looking for stocks that have made considerable gains in recent weeks could consider having a closer look at...

Victory Resources Corporation (OTCMKTS:VRCFF) Stock Rockets After Announcing A New Acquisition

Nowadays, lithium is in huge demand across several industries and hence, it the rally in the Victory Resources Corporation (OTCMKTS:VRCFF) stock the...

Vitality Biopharma Inc (OTCMKTS:VBIO) treats serious neurological and inflammatory disorders for the treatment of microbes and other “superbug” pathogens. They recently applied for patents utilizing and unlocking the power of cannabinoids. Shares have followed a similar pattern for the cannabis sector with an upstart rally followed by a pulling back leaving price volatility and volume spurts. VBIO shares remain liquid even on slower days.

But a look at the chart shows prices rallying from under $1.00 (.85 cents) to $4.25 into year-end, then falling back to as low as $1.25 this year so far. Again, shares have been volume doubling on the upside quickly and then falling like a stone. Keep in mind, much of the cannabis sector has been performing this way.

Vitality Biopharma Inc (OTCMKTS:VBIO) is a company dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. VBIO recently announced that they have obtained positive results demonstrating antimicrobial activity of cannabinoids and filed for patent protection on the use of cannabinoid compounds for the treatment of microbes including Clostridium difficile and other “superbug” pathogens.

Utilizing a list of the top drug-resistant pathogens from the United States Centers for Disease Control and Prevention (CDC), Vitality researchers screened for antimicrobial activity in their portfolio of compounds. VBIO discovered new antimicrobial activities for cannabinoids. As a result, they filed for patent protection on the use of cannabinoids and cannabinoid prodrugs for the treatment of multiple pathogenic bacterial infections.

Find out when $VBIO stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

At the top of the CDC’s list is Clostridium difficile (C. diff), which is classified as an urgent threat to human health. The CDC reported in 2015 that it infected almost 500,000 Americans and was directly responsible for 15,000 deaths. VBIO successfully demonstrated antimicrobial reactivity of a cannabinoid against C. diff, and is currently conducting follow-on studies designed to enable pharmaceutical use of their targeted cannabinoid prodrugs for this application.

Vitality Biopharma Inc (OTCMKTS:VBIO) also confirmed that cannabinoids have antimicrobial activity towards methicillin-resistant Staphylococcus aureus (MRSA). The pathogen that was recently listed on the World Health Organization’s (WHO) list of priority pathogens posing a significant threat to human health globally. Additional antimicrobial activity was seen towards other antibiotic-resistant bacterial species that were included on the CDC and WHO lists. VBIO is seeking broad intellectual property coverage for use of cannabinoids against these pathogens as well.

“Our cannaboside prodrugs enable the targeted delivery of cannabinoids into the large intestine, where C.diff infections colonize, take over, and can cause severe damage. Our compounds are uniquely suited for performing this task, and it’s now clear they may provide benefits to gut health through multiple mechanisms,” said Dr. Brandon Zipp, Director of R&D at Vitality. Robert Brooke, the Company’s CEO, adds that, “This is a logical extension of our work that has been focused on gastrointestinal disease, and represents a new opportunity to treat a serious and life-threatening condition.”

The challenge from a technical standpoint is getting shares in Vitality Biopharma, Inc. (OTCMKTS: VBIO) to close above the current highs for the year. They seem to be turning higher and have made a few runs at this $3.30 level, but you need multiple closes above this price. As mentioned, the volume has been good so liquidity always adds more players.

VBIO is also driven by news in addition to the sector volume itself, so these shares are ones to keep an eye on in cannabis. They are aiming at serious pathogens and are pointed in the right direction establishing an important place in a sector that has huge upside – which medical cannabis surely does.

The current market-cap for VBIO is $38.18M and they are looking like an undervalued stock with serious pharmaceutical substance. VBIO could not only be an exciting story, but a real revenue stream for investors. For continuing coverage on shares of $VBIO stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!

 

Latest article

Alibaba Group Holding Limited (OTCMKTS:BABAF) Big Volume with Possible 60% Upside

Alibaba Group Holding Limited (OTCMKTS:  BABAF) is an over the counter stock traded on the OTC Pink markets in the Consumer Discretionary...

Trans Global Group Inc (OTCMKTS:TGGI) Stock In Focus After Operational Updates

The Trans Global Group Inc (OTCMKTS:TGGI) stock may not have been in the news today yet but it...

Why Hycroft Mining (NASDAQ:HYMC) Stock Shot Up 700%

If you are on the hunt for stocks that may have made major gains over the course of the past week, then...

Secure Paymentz releases banking software demo on Github

This is a paid announcement from one of our advertising partners. How to Leverage Your Trading Position by Secure...

Advanced Asset Management Announces New Website Launch

This is a paid announcement from one of our advertising partners. Financial Planner in Grandville, Michigan
Şehirler arası nakliyat ve Şehirler arası taşımacılık konusunda en uygun fiyatlar ve en kaliteli hizmet.
ofis taşıma firmaları ve ofis taşıma konusunda en uygun fiyatlar ve en kaliteli hizmet.
SmsVerifyer.com Affordable best sms verification service